Clinical Efficacy of Banan® in Otorhinolaryngological Infections

Abstract

Infections constitute a high percentage of the diseases treated in the field of otorhinolaryngology. We examined the efficacy and safety of Banan® and the trends of the organisms causing infections in 300 patients. A total of 262 strains of organisms were detected and S. aureus was predominant. The efficacy rate of Banan® was 89.5% for acute infections, 62.8% for chronic ones, and 76.5% overall.
Side effects occurred in 2.7% of the patients and the majority of them were gastrointestinal disorders.
Thus, we concluded that this drug was useful in the field of otorhinolaryngology.